Paper2127348
In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
Rolston KV and 5 others. Antimicrob Agents Chemother, 1990. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients. Papers, record 2127348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2127348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Infective Agents | Major topic |
| Bacteria | Major topic |
| Bacterial Infections | Major topic |
| Fluoroquinolones | Major topic |
| Neoplasms | Major topic |
| Ciprofloxacin | |
| Fleroxacin | |
| Gram-Negative Bacteria | |
| Gram-Positive Bacteria | |
| Humans | |
| Microbial Sensitivity Tests |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7447427 | Method of reliable determination of minimal lethal antibiotic concentrations. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7447427 | PubMed |
| 2 | 3538962 | Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3538962 | PubMed |
| 3 | 3466563 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3466563 | PubMed |
| 4 | 3037899 | Norfloxacin for prevention of bacterial infections in granulocytopenic patients. | Am J Med | 1987 | https://conductscience.org/library/papers/3037899 | PubMed |
| 5 | 3284340 | Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis. | Am J Med | 1988 | https://conductscience.org/library/papers/3284340 | PubMed |
| 6 | 2393270 | In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2393270 | PubMed |
| 7 | 2732120 | In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients. | J Antimicrob Chemother | 1989 | https://conductscience.org/library/papers/2732120 | PubMed |
| 8 | 2802544 | In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2802544 | PubMed |
| 9 | 2558617 | In vitro activity of AT-4140 against clinical bacterial isolates. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2558617 | PubMed |
| 10 | 2327763 | Pharmacokinetics of a novel quinolone, AT-4140, in animals. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327763 | PubMed |
| 11 | 2327768 | Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2327768 | PubMed |
| 12 | 2653217 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2653217 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9210669 | Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9210669 | PubMed |
| 8851609 | Susceptibilities of non-Pseudomonas aeruginosa gram-negative nonfermentative rods to ciprofloxacin, ofloxacin, levofloxacin, D-ofloxacin, sparfloxacin, ceftazidime, piperacillin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and imipenem. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8851609 | PubMed |
| 7601015 | Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections. | Drugs | 1995 | https://conductscience.org/library/papers/7601015 | PubMed |
| 1906696 | In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1906696 | PubMed |
| 1666499 | Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1666499 | PubMed |
| 1503453 | In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1503453 | PubMed |
| 1320362 | In vitro activity of sparfloxacin compared with those of five other quinolones. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1320362 | PubMed |
| 1314175 | In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. | Eur J Clin Microbiol Infect Dis | 1992 | https://conductscience.org/library/papers/1314175 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2127348
GET https://conductscience.org/api/papers/v1/2127348/authors